This inventor holds 5 USPTO granted patents and 9 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Genequantum Healthcare (Suzhou) Co., Ltd.. Active years: 2023-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2025
Title: The Innovative Contributions of Paul H Song
Introduction
Paul H Song is a notable inventor based in Suzhou, China. He has made significant contributions to the biopharmaceutical field, particularly in the development of innovative drug conjugates. With a total of four patents to his name, his work has the potential to impact cancer treatment and drug delivery systems.
Latest Patents
Among his latest patents are "Exatecan derivatives, linker-payloads, and conjugates and thereof," which focuses on antibody-drug conjugates and their preparation processes. Another important patent is "Linkers, conjugates and applications thereof," which relates to a linker molecule designed for targeting molecule-drug conjugates, along with the corresponding conjugate and its preparation and use.
Career Highlights
Paul has worked with Genequantum Healthcare (Suzhou) Co., Ltd. and Genequantum Healthcare Co., Ltd., where he has been instrumental in advancing biopharmaceutical innovations. His expertise in the field has led to the development of cutting-edge technologies that enhance drug efficacy and safety.
Collaborations
Throughout his career, Paul has collaborated with notable professionals, including Gang Qin and Mingyu Hu. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Paul H Song's contributions to the biopharmaceutical industry through his patents and collaborations highlight his role as a key innovator in the field. His work continues to pave the way for advancements in drug development and delivery systems.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile